Company intelligence / Profile preview

Noble Growth

Sykesville, Maryland, United Statesnoblegrowthcorp.com ↗

Ownership: Private
Development stage: Commercial

Overview

Noble Life Sciences is an advanced preclinical contract research organization providing comprehensive solutions for drug, vaccine, and device development. Its services span in vitro and in vivo testing, pharmacology, toxicology, GLP-compliant studies, bioanalytical services, study design/protocol development, data management/analysis. The company enables pharmaceutical clients to accelerate their R&D programs with expert guidance and robust scientific support.

Modalities: Small moleculeBiologicGene therapyVaccine
Industry: Contract Research Organization

Drug pipeline

5 assets

Cream N Tina

Commercial

Indications: Medical cannabis

4 more assets in the full pipeline.

Request access →

Partnerships

Multiple partnerships with biotech/pharma companies as clients; specific names include Jaguar Gene Therapy and Britecyte as referenced in testimonials

Beyond the preview

Go deeper on Noble Growth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noble Growth.

Explore the full profile